Study of a new automated insulin system for diabetes
Part of Hormones & metabolism clinical trials.
This study tests a new experimental automated insulin delivery system for people with type 1 or type 2 diabetes who already use a specific insulin pump (MiniMed 780G with Simplera Sync sensor). The goal is to see if the new system is safe and works well to help manage blood sugar.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 2 years or older
- You must have type 1 or type 2 diabetes for at least 6 months
- You must already use the MiniMed 780G pump with Simplera Sync sensor for at least 3 months
- Your HbA1c must be less than 11%
- You must take between 6 and 250 units of insulin daily
- You must be willing to follow the study schedule and training
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new automated insulin delivery system (a pump that helps manage blood sugar) in children and adults with diabetes. It aims to see if the system is safe and easy to use in daily life.
This study tests a new automated insulin pump system (NMX8) for adults with type 1 diabetes whose blood sugar is not well controlled (HbA1c above 7.5%). You must already be using a similar pump system. The goal is to see if this new device can help you get better control.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a new hybrid closed-loop system (an automated insulin pump) in people with type 1 diabetes whose blood sugar is not well controlled. It aims to see if the system is safe and helps improve glucose levels.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This study tests a new insulin pump system (MiniMed 780G) in children aged 7-17 who were recently diagnosed with type 1 diabetes. It aims to see if this pump helps control blood sugar better and improves quality of life compared to standard insulin shots or older pumps.
Hear when a new Diabetes (Insulin-requiring, Type 1 or Type 2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.